SPY423.11+2.25 0.53%
DIA339.45+0.67 0.20%
IXIC14,253.27+111.79 0.79%

BRIEF-ImmunoGen Reports Q1 Loss Per Share Of $0.17

05/10/2021 07:27
BRIEF-ImmunoGen Reports Q1 Loss Per Share Of $0.17

- ImmunoGen Inc IMGN.O:

  • IMMUNOGEN REPORTS RECENT PROGRESS AND FIRST QUARTER 2021 FINANCIAL RESULTS

  • Q1 LOSS PER SHARE $0.17

  • Q1 REVENUE $15.7 MILLION VERSUS REFINITIV IBES ESTIMATE OF $17.7 MILLION

  • Q1 EARNINGS PER SHARE ESTIMATE $-0.19 -- REFINITIV IBES DATA

  • TOP-LINE DATA FROM PIVOTAL SORAYA TRIAL OF MIRVETUXIMAB SORAVTANSINE IN OVARIAN CANCER EXPECTED IN Q4 OF 2021

  • EXPECTS THAT ITS CURRENT CASH WILL FUND OPERATIONS INTO SECOND HALF OF 2022

  • FINANCIAL GUIDANCE FOR 2021 REMAINS UNCHANGED

Source text for Eikon: ID:nBw9vFLnLa

Further company coverage: IMGN.O


(([email protected];))